Order Article Reprints

Gill S, Berry S, Biagi J, Butts C, Buyse M, Chen E, Jonker D, Mărginean C, Samson B, Stewart J, et al. Progression-Free Survival as a Primary Endpoint in Clinical Trials of Metastatic Colorectal Cancer. Current Oncology. 2011; 18(s2):5-10. https://doi.org/10.3747/co.v18is2.941

Gill, S., S. Berry, J. Biagi, C. Butts, M. Buyse, E. Chen, D. Jonker, C. Mărginean, B. Samson, J. Stewart, and et al. 2011. "Progression-Free Survival as a Primary Endpoint in Clinical Trials of Metastatic Colorectal Cancer" Current Oncology 18, no. s2: 5-10. https://doi.org/10.3747/co.v18is2.941

Gill, S., Berry, S., Biagi, J., Butts, C., Buyse, M., Chen, E., Jonker, D., Mărginean, C., Samson, B., Stewart, J., Thirlwell, M., Wong, R., & Maroun, J. A. (2011). Progression-Free Survival as a Primary Endpoint in Clinical Trials of Metastatic Colorectal Cancer. Current Oncology, 18(s2), 5-10. https://doi.org/10.3747/co.v18is2.941